Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
77.48 USD | -1.36% | -3.29% | +36.59% |
05-31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
05-10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.59% | 1.76B | |
+7.50% | 217B | |
+13.29% | 194B | |
+20.16% | 143B | |
+30.74% | 111B | |
+3.12% | 64.3B | |
+14.66% | 52.94B | |
+2.06% | 49.53B | |
-5.24% | 38.31B | |
-0.08% | 35.22B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept